Some of the tablets contained twice the active ingredient...and this drug is used to treat heart failure and abnormal heart rhythms...double dose posed danger of renal failure and toxicity....and death could also result from the excess....BD
Drug maker Actavis Totowa recently recalled its version, Digitek, late last month because the tablets may contain twice the active ingredient. The recall notice points out that taking too much can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and an unusually slow heartbeat. And death.
The notice adds that several injuries have already been reported. The drug is distributed by Mylan Pharmaceuticals under a Bertek label and by UDL Laboratories under a UDL label. Actavis Totowa also says that the drug is manufactured in the U.S. (in case you were idly wondering).
Retired registered nurse Yvonne Cordoba, who lives in National City, Calif., brought this to our attention. She'd already contacted a couple of pharmaceutical firms and the Food and Drug Administration (which called her back!) to inquire about the cause of the recall and what was being done about it. She doesn't take the drug herself but knows people who do -- and the potential risks to them of taking too much. (And she apparently missed her calling as an investigative reporter.)
Heard about the digoxin recall? Probably not. : Booster Shots : Los Angeles Times
0 comments :
Post a Comment